Last: | $3.30 |
---|---|
Change Percent: | 0.0% |
Open: | $3.2 |
Close: | $3.30 |
High: | $3.3359 |
Low: | $3.2 |
Volume: | 15,507 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.3 | $3.2 | $3.3 | $3.3359 | $3.2 | 15,507 | 05-03-2024 |
$3.2 | $3.13 | $3.2 | $3.21 | $3.13 | 4,305 | 05-02-2024 |
$3.24 | $3.07 | $3.24 | $3.24 | $3.07 | 6,643 | 05-01-2024 |
$3.07 | $3.06 | $3.07 | $3.1807 | $3.06 | 2,558 | 04-30-2024 |
$3.24 | $3.18 | $3.24 | $3.29 | $3.06 | 5,040 | 04-29-2024 |
$3.25 | $3.14 | $3.25 | $3.275 | $3.06 | 24,741 | 04-26-2024 |
$3.16 | $3.145 | $3.16 | $3.16 | $3.1001 | 24,409 | 04-25-2024 |
$3.24 | $3.12 | $3.24 | $3.2969 | $3.05 | 13,286 | 04-24-2024 |
$3.29 | $3.35 | $3.29 | $3.35 | $3.28 | 3,908 | 04-23-2024 |
$3.3 | $3.41 | $3.3 | $3.46 | $3.27 | 14,325 | 04-22-2024 |
$3.33 | $3.395 | $3.33 | $3.4 | $3.27 | 8,506 | 04-19-2024 |
$3.45 | $3.22 | $3.45 | $3.47 | $3.22 | 11,854 | 04-18-2024 |
$3.22 | $3.25 | $3.22 | $3.26 | $3.165 | 9,058 | 04-17-2024 |
$3.31 | $3.22 | $3.31 | $3.44 | $3.19 | 15,153 | 04-16-2024 |
$3.28 | $3.57 | $3.28 | $3.57 | $3.12 | 81,927 | 04-15-2024 |
$3.55 | $3.71 | $3.55 | $3.822 | $3.55 | 9,603 | 04-12-2024 |
$3.7 | $3.86 | $3.7 | $3.86 | $3.7 | 4,448 | 04-11-2024 |
$3.89 | $3.8071 | $3.89 | $3.89 | $3.7656 | 10,024 | 04-10-2024 |
$3.8503 | $3.89 | $3.8503 | $3.98 | $3.8 | 41,027 | 04-09-2024 |
$3.86 | $3.77 | $3.86 | $3.9 | $3.7 | 117,520 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Inventiva S.A. Company Name:
IVA Stock Symbol:
NASDAQ Market:
Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmaceu...
Daix (France), Long Island City (New York, United States), March 28, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmace...
Revenues at €17.5 million for the full year of 2023 up 43.4% compared to €12.2 million for 2022 Cash and cash equivalents at €26.9 millio...